The cell and gene therapy market continues to advance, thanks to its potential to treat cancers and other severe diseases. While the pandemic has had a negative impact on companies specializing in cell and gene therapies, it has also catalyzed interest in cold-chain logistics while highlighting the promise of new therapy types. Organizations interested in…